Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a vaccine therapy in combination with sargramostim for soft tissue sarcoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• sargramostim (sargramostim)

Snippet

Sponsor: Columbia University | Conditions: Sarcoma | Phase 1 | Status: TERMINATED